NICE recommends drug treatment for long-term insomnia
Daridorexant has been recommended as a second-line treatment for long-term insomnia by the National Institute for Health and Care Excellence.
The drug is taken as a tablet, once per night, half an hour before going to bedMICROGEN IMAGES/SCIENCE PHOTO LIBRARY
Get unlimited access to all content
You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading
Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content
You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading
Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content
You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading
Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Get unlimited access to all content
You’ve reached your limit of premium articles on The Pharmaceutical Journal for this month.
Already an RPS member or registered? Log in
Become a member of the RPS or subscribe to continue reading and access the full range of information and news on pharmacy.
Become a member or subscribe
Register for free to keep on reading
Access two premium articles as a registered user.
Register
Already an RPS member or registered? Log in
Last updated
